Actively Recruiting
NorMIGS - a Study of Micro-invasive Glaucoma Surgery
Led by Oslo University Hospital · Updated on 2022-11-29
100
Participants Needed
1
Research Sites
318 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.
CONDITIONS
Official Title
NorMIGS - a Study of Micro-invasive Glaucoma Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
- Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS
- Ability to cooperate fairly well during the examinations
- Willing to participate in the study and capable of providing informed consent
You will not qualify if you...
- High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Ophthalmology, Oslo University Hospital
Oslo, Norway, 1163
Actively Recruiting
Research Team
O
Olav Kristianslund, MD PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here